Security key
04351P101
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 48,248,343
- Total 13F value
- $7,132,005,530
- Share change
- +198,875
- Put/Call ratio
- 34%
- SEC-reported price per share
- $147.90
- Number of holders
- 149
- Value change
- +$39,025,561
- Number of buys
- 90
- Number of sells
- 60
- Shares outstanding
- 62,915,156
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2020
Institutions
149
Top holders
10
ASND full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2020
Previous quarter: Q1 2020
Ascendis Pharma A/S SEC filings
Ascendis Pharma A/S company facts
Broader feeds
Reporting periods
Holder history for CUSIP 04351P101
Recent filing periods:
Ownership snapshot
Top reported holders of ASND - Ascendis Pharma A/S - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PRICE T ROWE ASSOCIATES I...
Disclosed value leader
PRICE T ROWE ASSOCIATES I...
Comparable rows
15/15
Latest evidence
31 Mar 2020
13F
Lead comparable stake: 11%
Showing 1-6 of 15 holder rows.
Quick read
PRICE T ROWE ASSOCIATES INC /MD/ leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PRICE T ROWE ASSOCIATES INC /MD/'s linked filing trail.
Comparable ownership
Top 5
PRICE T ROWE ASSOCIATES INC /MD/
11%
RA CAPITAL MANAGEMENT, L.P.
7.8%
FMR LLC
7.6%
BAKER BROS. ADVISORS LP
5.4%
ORBIMED ADVISORS LLC
5.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
11%
|
$809,984,000
7,192,829 shares
|
— | 31 Mar 2020 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
7.8%
|
$553,473,000
4,914,955 shares
|
— | 31 Mar 2020 |
| FMR LLC |
13F
Company
|
7.6%
|
$537,596,000
4,773,963 shares
|
— | 31 Mar 2020 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
5.4%
|
$381,778,000
3,390,270 shares
|
— | 31 Mar 2020 |
| ORBIMED ADVISORS LLC |
13F
Company
|
5.2%
|
$370,194,000
3,287,400 shares
|
— | 31 Mar 2020 |
| Artisan Partners Limited Partnership |
13F
Company
|
4.1%
|
$288,209,000
2,559,356 shares
|
— | 31 Mar 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
149
Shares
48,248,343
Rows available
149
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
143
Q2 2020 holders
149
Holder diff
6
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 value | Q2 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend